Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Keryx Biopharmaceuticals, Inc.
OKLAHOMA CITY, OK -- (Marketwired) -- 08/31/16 -- On August 26, 2016, a class action lawsuit was filed in the United States District Court for the District of Massachusetts against Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX). The complaint alleges …